Strategic Focus Target neuromusculoskeletal innovations and institutions with surgeon-developed medical devices, as VB specializes in venture capital and private equity for life-changing MSK technologies, indicating high interest in scalable, clinically validated solutions.

Global Market Reach Leverage VB portfolio’s track record of products sold in over 70 countries to position offerings for international expansion, distribution partnerships, and regulatory strategy support.

Operational Support Offer end-to-end commercialization and regulatory advisory services aligned with VB’s portfolio, highlighting potential collaboration on manufacturing scale, market access, and clinical adoption for MSK devices.

Financial Intensity Align sales pitches with VB’s capital-first approach by presenting compelling ROI, risk-adjusted exit value, and proven track record of creating >1.5B in exit value to reassure investors and strategics.

Strategic Partnerships Propose co-development or joint-venture opportunities with entities in VB’s ecosystem (e.g., Paradigm Spine, Centinel Spine, Woven Orthopedics) to accelerate adoption and expand technological footprints.